Q2 2025 Cibus Inc Earnings Call Transcript
Key Points
- Cibus Inc (CBUS) is making significant progress towards its commercial objectives, particularly in rice herbicide tolerance traits, which could generate over $200 million in potential annual royalty revenue.
- The company has achieved key milestones, including successful field trials, regulatory clearances, and customer engagement, positioning it for initial revenue recognition in 2026.
- Cibus Inc (CBUS) has signed an agreement with Semilao, a Colombian-based seed company, marking its fifth customer in the Americas, which enhances its market penetration in Latin America.
- The company is on track to reduce its annual cash usage to approximately $30 million by 2026, extending its financial runway.
- Cibus Inc (CBUS) is seeing strong interest from the consumer packaged goods industry for its bio-based products, with expectations for revenue ramp-up in bio fragrances starting in 2026.
- Cibus Inc (CBUS) reported a net loss of $26.6 million for the second quarter, compared to $28.5 million in the year-ago period.
- The company is still in the early stages of revenue generation, with second-quarter revenue at $933,000, reflecting only a slight increase from the previous year.
- The EU regulatory process for gene editing technologies has been delayed, which could impact the company's ability to capitalize on European market opportunities.
- Cibus Inc (CBUS) has implemented a reduction in force, resulting in one-time charges of approximately $0.5 million in the third quarter.
- The company's sustainable ingredients program, apart from bio fragrances, is not expected to generate significant revenue for a couple of years, delaying potential revenue streams.
Good afternoon and welcome to the Cibus second-quarter 2025 results conference call. (Operator Instructions) Please also note today's event is being recorded.
At this time I would like to turn the conference over to Carlo Broos, Interim Chief Financial Officer. Please go ahead.
Thank you and good afternoon. I would like to thank you for taking time to join us to receive the 2nd quarter 2025 financial results and business conference call and webcast. Presenting with me today is Peter Beaton, co-founder, Chief Executive Officer, President and CEO, and Greg, co-founder and Chief Scientific Officer.
Before we begin the call, I'd like to remind everyone that statements made on the call are webcast, including those regarding future financial results and future operational goals, and industry prospects are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call.
Please refer to CBS
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
